FIBROBIOLOGICS INC. - COMMON STOCK

1,6800

24-января-25 15:45:00

15 мин. задержка

Акции

+0,0800

+5,00%

Сегодняшний диапазон

1,5750 - 1,7400

ISIN

N/A

Источник

NASDAQ

FibroBiologics Announces 2024 Annual Meeting of Stockholders

15 май 2024 15:30:00 Источник Nasdaq GlobeNewswire
FibroBiologics Files 2024 First Quarter Report

14 май 2024 16:24:58 Источник Nasdaq GlobeNewswire
FibroBiologics to Present at the BIO International Convention 2024

07 май 2024 08:31:00 Источник Nasdaq GlobeNewswire
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids

25 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

11 апр 2024 08:31:00 Источник Nasdaq GlobeNewswire
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

04 апр 2024 08:31:00 Источник Nasdaq GlobeNewswire
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

28 мар 2024 08:31:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.